EPT - Condensed Consolidated Statements of Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common stock	Additional paid-in capital	Distributions in excess of accumulated earnings	Accumulated other comprehensive income, net	Noncontrolling interest
Balance at period beginning (in shares) at Dec. 31, 2024		64,280
Balance at period beginning at Dec. 31, 2024	$ 5,720,390	$ 6	$ 6,668,047	$ (1,155,662)	$ 24,655	$ 183,344
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	444,304			424,472		19,832
Change in fair value of derivatives and amortization of swap settlements	(13,521)				(13,064)	(457)
Change in fair value of marketable debt securities, net	87				84	3
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		49
Stock option and restricted stock plans, net	8,411		8,411
Sale of common stock, net	(101)		(101)
Equity based compensation costs	4,414		4,264			150
Changes in the redemption value and redemptions of redeemable noncontrolling interest	(2,073)		(1,702)			(371)
Distributions to noncontrolling interest	(16,485)					(16,485)
Redemptions of noncontrolling interest (in shares)		75
Redemptions of noncontrolling interest	(8,556)		6,795			(15,351)
Common stock dividends	(330,956)			(330,956)
Balance at period end (in shares) at Jun. 30, 2025		64,404
Balance at period end at Jun. 30, 2025	5,805,914	$ 6	6,685,714	(1,062,146)	11,675	170,665
Balance at period beginning (in shares) at Mar. 31, 2025		64,358
Balance at period beginning at Mar. 31, 2025	5,745,575	$ 6	6,672,346	(1,117,971)	15,620	175,574
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	231,526			221,362		10,164
Change in fair value of derivatives and amortization of swap settlements	(4,149)				(4,013)	(136)
Change in fair value of marketable debt securities, net	70				68	2
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		19
Stock option and restricted stock plans, net	2,902		2,902
Sale of common stock, net	(101)		(101)
Equity based compensation costs	2,359		2,279			80
Changes in the redemption value and redemptions of redeemable noncontrolling interest	1,454		1,473			(19)
Distributions to noncontrolling interest	(8,185)					(8,185)
Redemptions of noncontrolling interest (in shares)		27
Redemptions of noncontrolling interest	0		6,815			(6,815)
Common stock dividends	(165,537)			(165,537)
Balance at period end (in shares) at Jun. 30, 2025		64,404
Balance at period end at Jun. 30, 2025	5,805,914	$ 6	6,685,714	(1,062,146)	11,675	170,665
Balance at period beginning (in shares) at Dec. 31, 2025		64,442
Balance at period beginning at Dec. 31, 2025	5,708,632	$ 6	6,683,514	(1,148,195)	6,047	167,260
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	179,137			168,648		10,489
Reversal of unrealized gains upon the sale of marketable debt securities, net	(26)				(26)
Change in fair value of derivatives and amortization of swap settlements	3,501				3,385	116
Change in fair value of marketable debt securities, net	(293)				(282)	(11)
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		13
Stock option and restricted stock plans, net	93		93
Sale of common stock, net	(59)		(59)
Equity based compensation costs	6,190		5,986			204
Retirement of common stock, net (in shares)		(254)
Retirement of common stock, net	(61,915)		(61,915)
Changes in the redemption value and redemptions of redeemable noncontrolling interest (in shares)		67
Changes in the redemption value and redemptions of redeemable noncontrolling interest	890		612			278
Changes in noncontrolling interest from acquisition	0		(250)			250
Distributions to noncontrolling interest	(16,017)					(16,017)
Redemptions of noncontrolling interest	(1,562)		(1,436)			(126)
Common stock dividends	(333,055)			(333,055)
Balance at period end (in shares) at Jun. 30, 2026		64,268
Balance at period end at Jun. 30, 2026	5,485,516	$ 6	6,626,545	(1,312,602)	9,124	162,443
Balance at period beginning (in shares) at Mar. 31, 2026		64,310
Balance at period beginning at Mar. 31, 2026	5,601,356	$ 6	6,638,007	(1,208,590)	6,164	165,769
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	66,929			62,462		4,467
Reversal of unrealized gains upon the sale of marketable debt securities, net	(13)				(13)
Change in fair value of derivatives and amortization of swap settlements	3,143				3,039	104
Change in fair value of marketable debt securities, net	(69)				(66)	(3)
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		6
Stock option and restricted stock plans, net	312		312
Sale of common stock, net	(59)		(59)
Equity based compensation costs	3,240		3,135			105
Retirement of common stock, net (in shares)		(48)
Retirement of common stock, net	(11,702)		(11,702)
Changes in the redemption value and redemptions of redeemable noncontrolling interest	(1,585)		(1,712)			127
Distributions to noncontrolling interest	(8,000)					(8,000)
Redemptions of noncontrolling interest	(1,562)		(1,436)			(126)
Common stock dividends	(166,474)			(166,474)
Balance at period end (in shares) at Jun. 30, 2026		64,268
Balance at period end at Jun. 30, 2026	$ 5,485,516	$ 6	$ 6,626,545	$ (1,312,602)	$ 9,124	$ 162,443